What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: Roferon-A
96%DGNews: Roferon-A Now Licensed for Treatment of Chronic Hepatitis C
95%DGNews: Roferon-A Cleared for Marketing by FDA
85%DGNews: NIH Consensus On Hepatitis C Recommends Interferon Alpha
81%DGNews: CROI: Patients With HIV and HCV Taking Protease Inhibitors and/or Non-Nucleoside Reverse Transcriptase Inhibitors Appear to Have Greater Prevalence of Advanced Fibrosis
80%DGNews: FDA Approves Pegasys (Peginterferon Alfa-2a) For the Treatment of Hepatitis C
80%DGNews: New Invirase Resistance/Cross Resistance Data
78%DGNews: FDA Recommends Full Approval for Hivid(r) Combination Therapy
77%DGNews: Invirase Combined with Hivid Reduces Deaths by More Than Two Thirds
74%DGNews: FDA Advisory Committee Unanimously Recommends Approval of Pegasys (Peginterferon Alfa-2a) in Combination with Copegus (Ribavirin) for Hepatitis C
73%DGNews: Roche's Ribavirin Copegus Available In All EU Countries Within Months
72%DGNews: ASCO: "Smart Tablet" Xeloda (Capecitabine) Is Highly Effective And Makes Chemotherapy Easier For Patients
71%DGNews: Pegasys (Peginterferon alfa-2a) More Tolerable Treatment for Hepatitis C Patients
70%DGNews: Xeloda (Capecitabine) Approved For Breast Cancer Treatment In Europe
69%DGNews: Pegasys Marketing Authorisation Granted By European Commission COPEGUS
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.